Type 2 Diabetes and Weight Management — New Research Opportunities in Daytona
Arrow Clinical Trials in Daytona Beach is enrolling adults with Type 2 diabetes for a paid weight management research study. No-cost participation, compensation provided.
Managing Type 2 diabetes is hard enough. Managing it alongside significant weight challenges — the kind that medications and willpower have not fully resolved — is something else entirely. If you have been living with both, you already know how tightly they are tied together, and how frustrating it can be to make progress on one without it affecting the other.
A new class of investigational treatments is changing what is scientifically possible in this space. Arrow Clinical Trials in Daytona Beach is currently enrolling adults with Type 2 diabetes for a paid weight management research study — at no cost to participants, with compensation provided for time and travel.
The Diabetes-Weight Connection: Why Managing Both Is Hard
Type 2 diabetes and excess body weight are not just coincidental companions — they drive each other. Excess body fat, particularly around the abdomen and organs, releases fatty acids and inflammatory signals that disrupt how cells respond to insulin. To compensate, the pancreas produces more insulin. Over time, this elevated insulin output becomes unsustainable. Blood sugar rises, and Type 2 diabetes develops or worsens.
The reverse is also true: diabetes medications, lifestyle changes, and the metabolic effects of the condition itself can make weight loss harder than it already is for most people. You are not imagining it. The biology works against you.
What Current Treatments Miss
Standard care for Type 2 diabetes focuses primarily on blood sugar control. Metformin, sulfonylureas, insulin — these are tools for managing glucose. They are not designed to produce meaningful, sustained weight loss in most patients. Some can even contribute to weight gain over time, compounding the underlying problem.
Weight loss interventions, on the other hand, have traditionally been separate from diabetes management — diet programs, behavioral counseling, bariatric surgery for severe cases. The idea of a single treatment that targets both conditions simultaneously has been, until recently, largely out of reach for most people.
That gap is exactly what current clinical research is working to close.
How Clinical Studies Are Advancing Dual-Target Therapies
A new generation of incretin-based medications is producing results that would have seemed implausible a decade ago. GLP-1 agonists and emerging triple agonists — agents that target multiple gut hormone pathways at once — are delivering bariatric-surgery-level weight loss while also dramatically improving glucose control in people with Type 2 diabetes. They work by hitting appetite, insulin secretion, and energy expenditure in a coordinated way.
Early trial data suggests these agents don't just improve the numbers. They also reduce liver fat, improve lipid profiles, and may help with multiple obesity-related complications simultaneously. The research is still ongoing — which is why studies like the one at Arrow are critical.
What Participating in the Arrow Diabetes Study Involves
The study at Arrow Clinical Trials evaluates an investigational medication for adults with Type 2 diabetes who are overweight or living with obesity. Participants are randomly assigned to receive either the investigational treatment or a placebo — a standard design that ensures reliable results. Neither participants nor the research team know which is assigned during the trial.
The study lasts approximately 75 weeks, with regular check-ins to monitor health and progress throughout. All study-related care, tests, and procedures are provided at no cost. Your regular medical care continues unchanged — participation does not replace it.
Many participants find the level of clinical attention during a study exceeds what a typical office visit provides. Regular monitoring, close contact with the research team, and detailed tracking of health markers are built into the process.
Many notice more energy, better mobility, and less pain as weight comes off, which they often rate as just as important as lab improvements. They appreciate seeing glucose, blood pressure, and lipids improve — sometimes with fewer medications or lower doses — and some experience partial or full remission of type 2 diabetes in intensive programs.
Charlie Ross, MD, FAAFP, DABOM, DABLM
Chief Medical Officer
Who May Qualify
You may be eligible if you are an adult 18 or older who:
Has been diagnosed with Type 2 diabetes
Is on stable diabetes treatment
Has a body mass index (BMI) of 27 kg/m² or higher
Has had stable body weight in the 90 days before screening
All genders are welcome. No health insurance is required. The research team will screen all applicants to confirm eligibility at no cost and with no obligation to enroll.
Apply in Daytona Beach — No Cost to You
Arrow Clinical Trials is currently enrolling adults with Type 2 diabetes in Daytona Beach. The study is designed to be accessible — all study-related care is covered, and compensation is provided for your time and travel. There is no cost to participate and no insurance requirement.
If you are managing Type 2 diabetes and have struggled to make progress on weight, this study may be worth exploring. Learn more about the Weight & Type 2 Diabetes study and apply to see if you qualify.
Frequently Asked Questions
What are paid weight loss clinical trials near me?
Paid weight loss clinical trials are research studies that evaluate investigational treatments for obesity or weight management — and compensate participants for their time and travel. Arrow Clinical Trials in Daytona Beach is currently running a paid study for adults with Type 2 diabetes who are overweight or living with obesity.
Is there a diabetes weight loss study in Daytona Beach?
Yes. Arrow Clinical Trials in Daytona Beach is currently enrolling for a weight management and Type 2 diabetes study evaluating an investigational medication. Adults 18 and older with Type 2 diabetes and a BMI of 27 or higher may qualify.
Do I need health insurance to join a paid diabetes clinical trial?
No. All study-related care, procedures, and visits at Arrow Clinical Trials are covered at no cost. Health insurance is not required to participate.
How do I know if I qualify for a weight and type 2 diabetes clinical trial near me?
The research team at Arrow will conduct a screening process to determine your eligibility. There is no commitment required — just submit your information and the team will reach out to walk you through the next steps.
What type 2 diabetes research studies are available in Florida?
Arrow Clinical Trials in Daytona Beach is conducting a Phase 3 study evaluating an investigational weight management medication for adults with Type 2 diabetes. The study is open to residents across Volusia County and the surrounding area.
Active Studies
See if you qualify for a current clinical trial.
Explore Arrow's active clinical trials and find opportunities to participate in cutting-edge research right here in Daytona Beach.
